Obese women less likely to suffer from dangerous preeclampsia complications
SAN DIEGO, CA — Despite having higher rates of preeclampsia, a dangerous high-blood pressure disorder of late pregnancy, obese women may be less than half as likely to suffer strokes, seizures, and other serious complications of the disorder. The findings are among those from two new studies of preeclampsia by researchers at the Perelman School of Medicine at University of Pennsylvania showing how obesity may help clinicians identify risk for the condition or other complications. The second study highlighted risk factors, including obesity, for persistent high blood pressure after delivery among women with preeclampsia. The studies (posters 31C and 20B, respectively) will be presented at the American Congress of Obstetricians & Gynecologists' (ACOG) Annual Clinical and Scientific Meeting in San Diego.
Preeclampsia, marked by high blood pressure and protein in the urine (a sign of hypertension-related stress on the kidneys) occurs in five to eight percent of pregnancies. Although it usually arises in late pregnancy and resolves quickly after delivery, it can lead to serious complications for the mother and/or baby, and is one of the top causes of stillbirth and maternal death during pregnancy. In addition, recent research has shown that the long-term effects of preeclampsia may lead to an increased risk of heart disease for the mother later in life.
"We don't know enough about the factors that lead to more serious outcomes in preeclampsia, but results of studies like these are starting to give us a better understanding," said Sindhu Srinivas, MD, MSCE, an associate professor at the Perelman School of Medicine at the University of Pennsylvania, and director of Obstetrical Services at the Hospital of the University of Pennsylvania, who was a co-author of both studies.
In the first study, the researchers examined hospital records for 193 women who had been diagnosed with severe preeclampsia. This medical emergency features episodes of very high blood pressure ( greater than160 systolic or 110 diastolic) with immediate risks of serious and potentially fatal complications.
Comparing the obese and non-obese members of this group, the researchers found that the obese women were less than half as likely to have had any of the more serious outcomes of severe preeclampsia, which include stroke, liver failure, kidney failure, blood clotting disorders, and seizures (eclampsia).
The authors say the finding is somewhat surprising since obese women are known to have a higher rate of preeclampsia overall — and in fact, obesity is one of the leading risk factors for the condition. "We need to follow this up with further studies, but our findings here suggest that obese women may get a different, less dangerous form of preeclampsia that has a lower risk of immediate complications," said Lisa Levine, MD, an assistant professor of Obstetrics and Gynecology and senior author on the study. "While the immediate risks appear to be less, this does not speak to the long-term cardiovascular risks that accompany a history of having preeclampsia," Levine states.
The four trajectories of postpartum blood pressure
In the second study, Penn researchers tracked blood pressure before and after delivery in 96 women with preeclampsia. Blood pressure in such women usually returns to normal within a day or so of delivery, but not always, so the researchers sought to identify factors associated with persistent high blood pressure after delivery.
Results showed that women with preeclampsia tend to have one of four basic trajectories of blood pressure after delivery: blood pressure falling to normal levels within a day of delivery; blood pressure starting at very high levels and remaining high after delivery; blood pressure starting near-normal but rising after delivery; and blood pressure falling slowly after delivery but plateauing at mildly high levels.
The analysis revealed that women with the first, healthiest trajectory were, on average, young (24.75 years), with a modest weight (150 lbs) at their first prenatal visit , delivered their babies around 36.5 weeks of gestation, and were more likely to deliver vaginally. By contrast, women with the most worrisome trajectory – blood pressure starting very high and staying very high for days after delivery -were about 10 years older and 65 pounds heavier on average, delivered their babies around 33 weeks of gestation, and were more likely to deliver via caesarean section.
The researchers also found that persistent or rising blood pressure after delivery was associated with positive fluid balance – an excess of fluid intake over urinary output – in the period from hospital admission to a day after delivery.
"Fluid balance is an easily modifiable factor, and so we hope to investigate in future studies whether lowering this balance can speed up the resolution of hypertension after delivery," said lead author Adi Hirshberg, MD, a fellow in Obstetrics & Gynecology at Penn Medicine.
Other co-authors were, for the first study, Christina Paidas-Teefey and Celeste Durnwald, and for the second study, Mary Sammel.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $6.7 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2016 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital — the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2016, Penn Medicine provided $393 million to benefit our community.
Abramson Cancer Center of the University of Pennsylvania
The Abramson Cancer Center (ACC) of the University of Pennsylvania is a world leader in cancer research, patient care, and education. Its preeminent position is reflected in its continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 45 such Centers in the United States, and its longstanding "exceptional" rating by the NCI. The ACC's clinical program is comprised of a dedicated, multi-disciplinary team of physicians, nurse practitioners, nurses, social workers, physical therapists, nutritionists, and patient care coordinators. Each year, the Center has more than 90,000 outpatient visits, over 11,800 inpatient discharges, and provides 37,000 chemotherapy treatments and more than 66,000 radiation treatments to its patients. In addition, the ACC is home to more than 400 basic, translational, and clinical scientists who work in tandem to advance new treatments and cures for cancers of all kinds.